Treatment Clinical Trials in Zhengzhou, Henan
6 recruitingZhengzhou, Henan, China
Showing 1–6 of 6 trials
Recruiting
Phase 4
A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia
Clinical Characteristics and Treatment Outcomes of Malignant Tumor CachexiaMulticenter Observational Study
Changchun GeneScience Pharmaceutical Co., Ltd.495 enrolled1 locationNCT07243379
Recruiting
Phase 2
Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
Locally Advanced Cervical CancerFemale, Age ≥ 18 Years OldNo Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy+6 more
The First Affiliated Hospital of Zhengzhou University29 enrolled1 locationNCT07104149
Recruiting
Phase 2
Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial
Advanced Breast CancerTreatmentHR Low/HER2 Negative
Henan Cancer Hospital240 enrolled1 locationNCT06176534
Recruiting
Not Applicable
The Maintenance Treatment of "ITIVA" in AML Patients
Acute Myeloid LeukemiaMaintenance TreatmentMinor Residue Disease+5 more
Henan Cancer Hospital130 enrolled1 locationNCT06256627
Recruiting
Phase 3
A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma
Treatment-naїve Mantle Cell Lymphoma
Beijing InnoCare Pharma Tech Co., Ltd.356 enrolled22 locationsNCT05051891
Recruiting
Phase 3
Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
Esophageal CancerSurgeryNeoadjuvant Treatment+1 more
Henan Cancer Hospital400 enrolled1 locationNCT04280822